AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| KGD | Ann: Change in substantial holding | 04/02/25 | 0 | 1 | |||
|
|||||||
| KGD | Ann: Change of Director's Interest Notice | 04/02/25 | 0 | 1 | |||
|
|||||||
| KGD | Ann: Notice of Annual General Meeting/Proxy Form | 23/04/18 | 0 | 35 | |||
|
|||||||
| KGD | Ann: DFS Update | 09/04/18 | 0 | 201 | |||
|
|||||||
| KGD | Ann: GPR: Woodlark Definitive Feasibilty Study update | 09/04/18 | 0 | 118 | |||
|
|||||||
| KGD | gold | 06/04/18 | 0 | 392 | |||
|
|||||||
| KGD | Ann: Full Year Statutory Accounts - 2017 | 29/03/18 | 0 | 167 | |||
|
|||||||
| KGD | Ann: Reinstatement to Official Quotation | 22/03/18 | 0 | 153 | |||
|
|||||||
See All Discussions
ASX News